Medical Research Future Fund - Accelerated Research - Congenital Heart Disease

Overview

The Congenital Heart Disease (CHD) grant opportunity forms part of the Accelerated Research initiative, funded through the Medical Research Future Fund (MRFF). The CHD grant opportunity supports research to provide new diagnoses and treatment options for those suffering from congenital heart disease. For this grant opportunity $20 million is available over 5 years from 2019-20 to 2023-24. There is no minimum grant amount. The maximum grant amount is $10 million. The grant amount will be up to 100 per cent of eligible project costs. You must complete your project by 30 June 2024. Ideally projects will align with  the National Strategic Action Plan for Childhood Heart Disease, and could target the Research Priorities in the Action Plan in particular: preventing neurodevelopmental and mental health complications understanding the impact of prenatal and postnatal factors affecting the health of children born with CHD and their families, or exploring the role of exercise and increased activity in reducing the impact of CHD. You must ensure new research is complementary to, and does not duplicate work in the following MRFF Accelerated Research Investments: The Stem Cells Australia research study into development of human heart tissue for understanding heart disease, improving repair and reconstructing tissues for kids with heart defects. The Murdoch Children’s Research Institute project to enable the Australian Genomics Health Alliance to extend the Cardiovascular Genetic Disorders Flagship study, which aims to interrogate the genomic basis of disease in individuals and families with cardiomyopathies, arrhythmias and congenital heart disease.